Literature DB >> 23592245

Sirtuin 6: a review of biological effects and potential therapeutic properties.

Jade M Beauharnois1, Beatriz E Bolívar, John T Welch.   

Abstract

Sirtuins, possessing either histone deacetylase or mono-ribosyltransferase activity, regulate important pathways in bacteria, archaea and eukaryotes. SIRT6, an enzyme highly expressed in skeletal muscles, brain, heart, liver, and thymus, affects transcriptional regulation in a tissue-specific manner. This enzyme has a two-domain structure that consists of a large Rossmann fold and a smaller and structurally more varied sequence containing a Zn(2+)-binding motif. The C-terminus is required for proper nuclear localization, while the N-terminus is important for chromatin association and for intrinsic catalytic activity. SIRT6 promotes resistance to DNA damage and oxidative stress, the principal defects associated with age-related diseases. The modulation of aging and other metabolic functions by SIRT6 may be indicative of previously unrecognized regulatory systems in the cell. The propensity of individual SIRT6 molecules to undergo intramolecular mono-ADP-ribosylation, suggests this auto-ribosylation may contribute to the self-regulation of SIRT6 function. Until recently, SIRT6 was an orphan enzyme whose catalytic activity and substrates were unclear. It was known that, similar to the yeast Sir2 protein, human SIRT6 deacetylates histones and regulates DNA stability and repair; however, new mechanistic insights can be derived from the discovery of the highly substrate-specific histone deacetylase activity of SIRT6. This deacetylase activity promotes proper chromatin function in several physiologic contexts, to include telomere and genome stabilization, gene expression and DNA repair. By maintaining both the integrity and the expression of the mammalian genome, SIRT6 may help prevent cellular senescence. Moreover, successful molecular modulation of SIRT6 activity may lead to the development of new chemotherapeutic modalities. The action of SIRT6 is described in this review, with an emphasis on the cellular roles of the enzyme and the relation of those enzymatic functions to human biology and disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592245     DOI: 10.1039/c3mb00001j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  19 in total

1.  EPA and DHA elicit distinct transcriptional responses to high-fat feeding in skeletal muscle and liver.

Authors:  Hawley E Kunz; Surendra Dasari; Ian R Lanza
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-02       Impact factor: 4.310

2.  Biochemical characterization of sirtuin 6 in the brain and its involvement in oxidative stress response.

Authors:  Alessio Cardinale; Maria Chiara de Stefano; Cristiana Mollinari; Mauro Racaniello; Enrico Garaci; Daniela Merlo
Journal:  Neurochem Res       Date:  2014-11-01       Impact factor: 3.996

3.  SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts.

Authors:  Anna Engler; Fabienne Niederer; Kerstin Klein; Renate E Gay; Diego Kyburz; Giovanni G Camici; Steffen Gay; Caroline Ospelt
Journal:  J Mol Med (Berl)       Date:  2014-03-19       Impact factor: 4.599

Review 4.  Sirtuins: guardians of mammalian healthspan.

Authors:  William Giblin; Mary E Skinner; David B Lombard
Journal:  Trends Genet       Date:  2014-05-28       Impact factor: 11.639

Review 5.  The Role of Sirtuins in Antioxidant and Redox Signaling.

Authors:  Chandra K Singh; Gagan Chhabra; Mary Ann Ndiaye; Liz Mariely Garcia-Peterson; Nicholas J Mack; Nihal Ahmad
Journal:  Antioxid Redox Signal       Date:  2017-10-20       Impact factor: 8.401

6.  A proteomic perspective of Sirtuin 6 (SIRT6) phosphorylation and interactions and their dependence on its catalytic activity.

Authors:  Yana V Miteva; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2013-10-25       Impact factor: 5.911

Review 7.  Sirtuins as molecular targets, mediators, and protective agents in metal-induced toxicity.

Authors:  Alexey A Tinkov; Michael Aschner; Thuy T Nguyen; Abel Santamaria; Aaron B Bowman; Aleksandra Buha Djordjevic; Monica Maria Bastos Paoliello; Anatoly V Skalny
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

8.  SIRT6 Activator UBCS039 Inhibits Thioacetamide-Induced Hepatic Injury In Vitro and In Vivo.

Authors:  Fangzhou Jiao; Zongwei Zhang; Hongtu Hu; Yongxi Zhang; Yong Xiong
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

Review 9.  Protective effects of sirtuins in cardiovascular diseases: from bench to bedside.

Authors:  Stephan Winnik; Johan Auwerx; David A Sinclair; Christian M Matter
Journal:  Eur Heart J       Date:  2015-06-25       Impact factor: 29.983

10.  A Fifth of the Protein World: Rossmann-like Proteins as an Evolutionarily Successful Structural unit.

Authors:  Kirill E Medvedev; Lisa N Kinch; R Dustin Schaeffer; Jimin Pei; Nick V Grishin
Journal:  J Mol Biol       Date:  2020-12-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.